Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of Tuesday, October 6, 2026.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
Apnimed, Inc.
Market Cap
$807.22M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$805.85M
Return on Invested Capital (ROIC)
9.20%
TTM Avg
13.08%
3Y Avg
19.17%
5Y Avg
23.78%
Market Cap
$804.28M
Return on Invested Capital (ROIC)
-7.99%
TTM Avg
-8.85%
3Y Avg
-21.37%
5Y Avg
-42.56%
Market Cap
$819.78M
Return on Invested Capital (ROIC)
-37.39%
TTM Avg
-65.53%
3Y Avg
-61.64%
5Y Avg
-93.68%
Market Cap
$784.88M
Return on Invested Capital (ROIC)
-9.77%
TTM Avg
8.57%
3Y Avg
-11.39%
5Y Avg
-51.99%
Market Cap
$789.11M
Return on Invested Capital (ROIC)
-0.26%
TTM Avg
4.90%
3Y Avg
-0.53%
5Y Avg
1.15%
Market Cap
$825.76M
Return on Invested Capital (ROIC)
-94.76%
TTM Avg
-114.06%
3Y Avg
-144.57%
5Y Avg
-144.57%
Market Cap
$834.78M
Return on Invested Capital (ROIC)
-31.17%
TTM Avg
-29.64%
3Y Avg
-85.48%
5Y Avg
-85.48%
Market Cap
$841.42M
Return on Invested Capital (ROIC)
-28.69%
TTM Avg
-21.44%
3Y Avg
-33.52%
5Y Avg
-49.04%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Apnimed, Inc. (APMD) | $807.22M | N/A | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $805.85M | 9.20% | 13.08% | 19.17% | 23.78% |
| Ardelyx, Inc. (ARDX)vs › | $804.28M | -7.99% | -8.85% | -21.37% | -42.56% |
| Jade Biosciences, Inc. (JBIO)vs › | $819.78M | -37.39% | -65.53% | -61.64% | -93.68% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $784.88M | -9.77% | 8.57% | -11.39% | -51.99% |
| AdaptHealth Corp. (AHCO)vs › | $789.11M | -0.26% | 4.90% | -0.53% | 1.15% |
| Alumis Inc. (ALMS)vs › | $825.76M | -94.76% | -114.06% | -144.57% | -144.57% |
| Beta Bionics, Inc. (BBNX)vs › | $834.78M | -31.17% | -29.64% | -85.48% | -85.48% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $841.42M | -28.69% | -21.44% | -33.52% | -49.04% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $764.02M | -23.16% | -53.28% | -63.06% | -59.41% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
